font size:

Study References

  1. Stahl SM. CNS Spectrums. 2007;12(10):739-44.
  2. Stahl SM. (2008). New York: Cambridge University Press.
  3. Mann J. N Engl J Med. 2005;353:1819-34.
  4. Rush J. et al. 2004;25:119-42.
  5. U.S. Department of Health & Human Services national institutes of Health. NIH publication no. 07-3561.revised 2007.
  6. Trivedi M et al. Am J Psych. 2006;163:24-40.
  7. Fava M & Rush J. 2006;75:139-53.
  8. Guyton AC & Hall JE. WB Saunders, Philadelphia, U.S.A.;1996.
  9. Yildiz A, Gönül AS and Tamam L. Bulletin of Clinical Psychopharmacology. 2002;12(4):194-200.
  10. Bottiglieri T. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2005;29:1103-12.
  11. Kelly CB et al. J Psychopharmacol. 2004;18(4):567-71.
  12. Papakostas GI et al. 2004;65(8):1090-5.
  13. Arinami T. 1997;74:526-528.
  14. Willems FF et al. 2004;141(5):825-30.
  15. Alpert JE et al. Annals of Clin Psych. 2002;14(1):33-38.
  16. Coppen A et al. J. Affective Disorders, 1986;10:9-13.
  17. Coppen A & Bailey J. J Affective Disorders, 2000;60:121-30.
  18. Godfrey PSA et al. The Lancet. 1990;336:392-95.
  19. Passeri M et al. Aging Clin Exp Res. 1993;5:63-71.
  20. Guaraldi et al. Annals Clin Psych. 1993;5(2):101-5.
  21. Di Palma C et al. Curr Therapeutic Research. 1994;55(5):559-68.
  22. Guaraldi et al. Annals Clin Psych. 1993;5(2):101-5.
  23. Deplin Clinical Evaluation Patient Response Survey. January 2007 - February 2008. Data on file.
  24. Skolnik P et al. Life Sciences. 2003;73:3175-9.
  25. Deplin Full Prescribing Information. February 2008.
  26. Alpert M, Silva R, & Pouget E. Journal Clin Pharmacology. 2003;23(3):309-13.
  27. Fava M et al. Am J Psychiatr. 1997;154(3):426-8.
  28. Alpert JE & Fava . Nutrition Reviews. 1997;55(5):145-9.
  29. Coppen A. & Bolander-Gouaille C. 2005;19(1):59-65.
  30. Papakostas G et al. Psychiatry Research: Neuroimaging. 2005;140:301-7.
  31. Levitt A & Joffe R. Biol Psychiatry. 1989;25:867-72./
  32. Wesson VA, Levitt A, & Joffe R. J of Psychiatry Research. 1994;53(3):313-22.
  33. Abou-Saleh MT & Coppen A. Acta Psychiatry Scand. 1989;80:78-82.
  34. Bottiglieri T et al. J. Neurol Neurosurg Psychiatry. 2000;69;228-32.
  35. Alpert JE et al. Nutrition. 2000;16(7/8):544-81.
  36. Procopciuc LM et al. Poster Presentation 5. P86 presented at Biol Psych. 2005.
  37. Bjelland I et al. Arch Gen Psychiatry. 2003;60(6):618-26.
  38. Akoglu B et al. Euro J Clin Nutrition. 2007;1-6.
  39. Scott JM and Weir DG. The Lancet.. 1981;2:337-40.
  40. Wright AJA, Dainty JR, & Finglas PM. British J Nutr. 2007;98:667-675.
  41. Troen AM et al. J Nutr. 2006;136:189-94.
  42. Akoglu B et al. Eur J Nutr. 2004;43:93-9.
  43. PDR® For Nutritional Supplements. 2001: ISBN: 1-56363-364-7:157-67.

Deplin® (7.5mg L-methylfolate) is a prescription medical food for the dietary management of suboptimal folate levels in depressed patients.

Legal Disclaimer / Privacy Notice
Deplin.com © 2008